Vaccine News and Research

Latest Vaccine News and Research

The public health impact of the SARS-CoV-2 Omicron subvariant BA.5 relative to BA.2 in Denmark

Researchers conducted a nationwide study in Denmark to assess the public health impact of the SARS-CoV-2 Omicron subvariant BA.5 relative to BA.2.

22 Oct 2022

Modeling study suggests the possibility of Japanese encephalitis virus outbreak in Australia

A paper from a research team, which included mathematical modeling expertise from LSHTM and was led by the QIMR Berghofer Medical Research Institute in Brisbane, has suggested that up to 750,000 people across Australia could be at risk of exposure to Japanese encephalitis (JEV).

21 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 (COVID-19) vaccination.

20 Oct 2022

Are pediatric COVID-19 samples less infectious?

Researchers determine whether children are less hospitable to SARS-CoV-2 and, as a result, pose a lower risk of a viral spread than adults.

20 Oct 2022

Scientists map structure of the hepatitis C virus E1E2 glycoprotein complex

A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at high resolution, critical proteins that stud the surface of the Hepatitis C virus (HCV) and enable it to enter host cells.

20 Oct 2022

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

20 Oct 2022

Mayo Clinic scientists awarded $12.1 million NCI grant for breast cancer research

A team of researchers from Mayo Clinic Comprehensive Cancer Center has been awarded a five-year, $12.1 million Specialized Program of Research Excellence (SPORE) grant in breast cancer from the National Cancer Institute.

20 Oct 2022

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

Black, Hispanic, and American Indian/Alaska Native (AI/AN) adults in the United States are more likely to be hospitalized with flu, as well as less likely to be vaccinated against flu, according to a new CDC Vital Signs report.

20 Oct 2022

KHN’s ‘What the Health?’: Biden hits the road to sell Democrats’ record

What do pandemic preparedness, mental health care services, and over-the-counter hearing aids have in common? They are all things President Joe Biden touted on the campaign trail this week as he tries to maintain Democrats' majorities in Congress in the midterm elections Nov. 8.

20 Oct 2022

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Researchers from the U.K. used data from clinical trials of the Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 nCoV-19 to understand the genetic factors contributing to the individual variations in the antibody responses to the vaccine.

20 Oct 2022

When COVID-19 hit, life expectancy plummeted worldwide

In a recent study published in the journal Nature Human Behavior, researchers estimated life expectancy (LE) changes in 29 high- and middle-income countries since 2020, when the coronavirus disease 2019 (COVID-19) pandemic began.

20 Oct 2022

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Scientists determine the risk of myocarditis and pericarditis among young individuals who have received mRNA-based COVID-19 vaccines.

19 Oct 2022

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

A recent study investigates poorer vaccine responses observed in the elderly following receipt of a COVID-19 booster vaccination dose.

19 Oct 2022

Study shows the importance of both obesity and biological sex in COVID-19 outcomes

A new animal study from Katherine Lee, a researcher with the West Virginia University School of Medicine, investigates why individuals with obesity may have a particularly difficult time fending off SARS-CoV-2, the virus that causes COVID-19.

19 Oct 2022

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

A recent study under review at the journal Scientific Reports and currently available on the Research Square* preprint server reported the development of a robust pipeline for fabricating an mRNA vaccine portfolio to combat current and future coronavirus outbreaks, other infectious diseases, and cancer.

19 Oct 2022

Study reveals high level of hybrid immunity in general Swiss population

A recent study covering the general Swiss population has evaluated the development of hybrid immunity during the pandemic wave dominated by the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Oct 2022

Adaptation-proof SARS-CoV-2 vaccine design is one step closer to reality

A vaccine design approach that could protect against new variants of SARS-CoV-2, the virus that causes COVID-19, but also potentially protects against other coronaviruses is one step closer to reality as a result of Penn State College of Medicine research.

18 Oct 2022

Scientists develop a pseudovirus system to deep mutational scan the full SARS-CoV-2 spike

A pseudovirus system based on deep mutational scanning determines how SARS-CoV-2 mutations can affect its ability to escape neutralization.

18 Oct 2022

SARS-CoV-2 placentitis may cause placental destruction and stillbirth in women not vaccinated for COVID-19

As compared to healthy women, pregnant women infected with SARS-CoV-2 are at a high risk of fatal clinical outcomes.

18 Oct 2022

Vaccine News and Research

Latest Vaccine News and Research

The public health impact of the SARS-CoV-2 Omicron subvariant BA.5 relative to BA.2 in Denmark

Modeling study suggests the possibility of Japanese encephalitis virus outbreak in Australia

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

Are pediatric COVID-19 samples less infectious?

Scientists map structure of the hepatitis C virus E1E2 glycoprotein complex

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

Mayo Clinic scientists awarded $12.1 million NCI grant for breast cancer research

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

KHN’s ‘What the Health?’: Biden hits the road to sell Democrats’ record

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

When COVID-19 hit, life expectancy plummeted worldwide

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

Study shows the importance of both obesity and biological sex in COVID-19 outcomes

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

Study reveals high level of hybrid immunity in general Swiss population

Adaptation-proof SARS-CoV-2 vaccine design is one step closer to reality

Scientists develop a pseudovirus system to deep mutational scan the full SARS-CoV-2 spike

SARS-CoV-2 placentitis may cause placental destruction and stillbirth in women not vaccinated for COVID-19

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in